+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2016-2020 Hematology and Flow Cytometry Testing in the US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations

  • ID: 3635281
  • Report
  • Region: United States
  • 306 pages
  • VPG Market Research
1 of 2

FEATURED COMPANIES

  • Abbott
  • Beckman Coulter/Danaher
  • Bio-Rad
  • Competitive Assessments
  • Iris Diagnostics/Danaher
  • Roche
  • MORE
This comprehensive report contains 306 pages, 59 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in US hematology and flow cytometry hospital, commercial and point-of-care/POC markets during the next five years.  The report explores business and technological trends in the US hematology and flow cytometry markets; provides market share estimates, test volume forecasts, and instrument placements; compares features of major analyzers; profiles leading competitors and emerging market entrants; and suggests specific product and marketing opportunities facing suppliers.
Note: Product cover images may vary from those shown
2 of 2

Loading
LOADING...

3 of 2
Competitive Assessments

- Abbott
- Agilent Technologies
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio-Rad
- CellaVision
- Horiba
- Iris Diagnostics/Danaher
- Nihon Kohden
- Ortho-Clinical Diagnostics
- Roche
- Siemens
- Sysmex
Note: Product cover images may vary from those shown
Adroll
adroll